In these studies, a larger percentage of patients in the pramipexole group were diagnosed with incident HF compared to the placebo group; however, the difference did not reach statistical significance [ 13 ].
← all excerpts
Non-Ergot Dopamine Agonists Do Not Increase the Risk of Heart Failure in Parkinson's Disease Patients: A Meta-Analysis of Randomized Controlled Trials.
1
—
—